Find the right fit for you - faster
Get tailored insights about working at Digital Diagnostics in one quick step.
Digital Diagnostics Snapshot
Digital Diagnostics Inc. is a pioneering AI diagnostics company on a mission to benefit patients by transforming the accessibility, affordability, equity, and quality of global healthcare through the application of technology in the medical diagnosis and treatment process.
LumineticsCore™ (formerly IDx-DR) is Digital Diagnostics’ flagship product that detects diabetic retinopathy (including macular edema) at the point-of-care in primary care, community clinics, lab, and retail settings. After completing a rigorous prospective, preregistered clinical trial at primary care sites across the country, LumineticsCore™ became the first FDA De Novo cleared fully autonomous AI diagnostic system to detect disease without a physician’s assistance or overread. IDx-DR is deployed at the point-of-care in health systems across the United States and Europe. In addition, the FDA determined that IDx-DR met the standards for ‘breakthrough device’ designation.
Since gaining clearance, Digital Diagnostics has diligently worked from within the healthcare system to establish AI diagnosis as the new standard of care. From real-world clinic launch & EMR integration, to the creation of the first ever autonomous AI CPT® category 1 code for billing and payment, to inclusion in the American Diabetes Association (ADA)’s 2020 Standards of Care in Diabetes, Digital Diagnostics has proven that intelligent diagnostic platforms can be deployed safely and responsibly to improve patient outcomes and increase healthcare productivity.
Digital Diagnostics is in use at over 20 health systems and our customers have tested thousands of patients and identified hundreds of patients with disease who were previously undiagnosed.
Tomorrow, Digital Diagnostics is launching additional AI platforms for the detection of a wide range of disease states beyond the eye.
Since gaining clearance, Digital Diagnostics has diligently worked from within the healthcare system to establish AI diagnosis as the new standard of care. From real-world clinic launch & EMR integration, to the creation of the first ever autonomous AI CPT® category 1 code for billing and payment, to inclusion in the American Diabetes Association (ADA)’s 2020 Standards of Care in Diabetes, Digital Diagnostics has proven that intelligent diagnostic platforms can be deployed safely and responsibly to improve patient outcomes and increase healthcare productivity.
Digital Diagnostics is in use at over 20 health systems and our customers have tested thousands of patients and identified hundreds of patients with disease who were previously undiagnosed.
Tomorrow, Digital Diagnostics is launching additional AI platforms for the detection of a wide range of disease states beyond the eye.
